Yes, alcoholism is a recognized medical condition. The American Medical Association has classified it as a disease since 1987, and it appears in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) under the formal name “alcohol use disorder,” or AUD. This isn’t just a policy label. Decades of neuroscience research show that chronic alcohol use physically changes the brain in ways that make it progressively harder to stop drinking, even when someone wants to.
How Alcohol Use Disorder Is Diagnosed
The DSM-5, which is the standard reference used by clinicians to diagnose mental health conditions, lists 11 criteria for alcohol use disorder. Meeting any two of them within a 12-month period qualifies as a diagnosis. The criteria cover a wide range of behaviors and experiences, including drinking more or longer than intended, being unable to cut down despite wanting to, spending a lot of time drinking or recovering from its effects, and experiencing cravings so strong you can’t think of anything else.
Other criteria focus on consequences: drinking interfering with work, school, or family responsibilities. Continuing to drink even though it’s damaging relationships. Giving up activities you used to enjoy in order to drink. Getting into dangerous situations while drinking, like driving or unsafe sex. Continuing despite worsening depression, anxiety, or other health problems. The final two criteria address physical dependence: needing more alcohol to feel the same effect (tolerance), and experiencing withdrawal symptoms like shakiness, sweating, insomnia, nausea, or seizures when alcohol wears off.
Severity is graded on a scale. Two to three criteria met means mild AUD. Four to five is moderate. Six or more is severe. This spectrum replaced the older, more binary distinction between “alcohol abuse” and “alcohol dependence,” reflecting the reality that problematic drinking exists on a continuum rather than as a single on/off switch.
What Alcohol Does to the Brain
The biological case for alcoholism as a medical condition rests heavily on what happens inside the brain with repeated use. Alcohol activates the brain’s reward circuits, triggering the release of feel-good signals through opioid receptors in a region called the nucleus accumbens. This is the same basic reward pathway involved in eating, sex, and other pleasurable activities, but alcohol can hijack it in ways that shift priorities over time.
With chronic drinking, something fundamental changes. The decision to pick up a drink gradually moves from a conscious, deliberate choice (governed by the brain’s prefrontal cortex, which handles planning and impulse control) to an automatic habit driven by deeper brain structures. Environmental cues, like a familiar bar, the sound of a bottle opening, or even a stressful situation, can trigger alcohol-seeking behavior through these habit pathways before the thinking parts of the brain have a chance to intervene.
At the same time, chronic alcohol exposure damages the prefrontal cortex itself, impairing the very functions you’d need to resist those automatic urges: impulse control, decision-making, and emotional regulation. In severe cases, these impairments can persist for months or even years after someone stops drinking. This is a key reason why willpower alone is often insufficient. The part of the brain responsible for exercising willpower has been physically compromised.
Physical Health Effects of Chronic Drinking
Alcohol use disorder doesn’t just affect the brain. It’s a systemic condition with consequences throughout the body. Alcohol is a confirmed carcinogen, linked to cancers of the mouth, throat, esophagus, colon, rectum, liver, and breast. A 2024 analysis estimated that alcohol accounts for 5.4% of new cancer cases and 4.1% of cancer deaths in the United States.
The liver takes an especially heavy toll. Alcohol-associated liver disease progresses through a spectrum: fatty liver first, then inflammation, then scarring (fibrosis and cirrhosis), and potentially liver cancer. This progression can happen over years or decades, often without obvious symptoms until the damage is advanced.
Alcohol is also the leading cause of chronic pancreatitis and the second leading cause of acute pancreatitis. It raises the risk of high blood pressure and heart rhythm problems like atrial fibrillation. In people with severe AUD and poor nutrition, a thiamine (vitamin B1) deficiency can cause a neurological emergency that, if untreated, progresses to a condition characterized by profound, permanent memory loss.
Why the “Disease” Label Matters
The AMA’s position is explicit: drug dependencies, including alcoholism, are diseases, and treating them is a legitimate part of medical practice. This classification has practical consequences. It means AUD qualifies for insurance coverage, it shapes how courts and employers handle alcohol-related issues, and it opens the door to medical treatment rather than relying solely on punishment or moral judgment.
The disease framing also aligns with what neuroscience shows. Just as type 2 diabetes involves a biological feedback loop where insulin resistance begets more insulin resistance, alcohol use disorder involves a neurological feedback loop where brain changes from drinking make it harder to stop drinking. Both conditions involve behavioral components (diet choices, drinking choices), both have genetic risk factors, and both require ongoing management rather than a one-time fix.
How AUD Is Treated Medically
Three FDA-approved medications currently exist for alcohol use disorder. One works by blocking the opioid receptors responsible for the pleasant sensations of drinking, which reduces cravings. Another eases the brain’s hyperexcitability during early sobriety, helping with the discomfort that makes people return to drinking. A third causes nausea and skin flushing if you drink while taking it, creating a strong physical deterrent.
For people who are physically dependent, stopping alcohol abruptly can be dangerous. Withdrawal symptoms range from tremors, sweating, and insomnia to seizures and delirium in severe cases. Medical withdrawal management typically lasts three to seven days and involves medications that calm the brain’s overexcited state during the transition. Patients who are malnourished or in severe withdrawal also receive thiamine supplementation to prevent neurological damage. People at risk for severe withdrawal, or those with other serious physical or psychiatric conditions, are generally managed in a hospital or inpatient setting.
Beyond medication, behavioral therapies remain central to treatment. Cognitive behavioral therapy, motivational interviewing, and mutual support groups like AA all have evidence behind them. Most effective treatment plans combine medication with some form of behavioral support, tailored to the individual’s severity and circumstances. Recovery timelines vary widely. Some people respond well to outpatient treatment, while others need months of structured care before the brain’s decision-making and impulse control systems recover enough to sustain sobriety independently.